Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer

Difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase (ODC), has promising activity against various cancers and a tolerable safety profile for long-term use as a chemopreventive agent. However, the anti-tumor effects of DFMO in ovarian cancer cells have not been entire...

Full description

Bibliographic Details
Main Authors: Woo Yeon Hwang, Wook Ha Park, Dong Hoon Suh, Kidong Kim, Yong Beom Kim, Jae Hong No
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/19/10255
_version_ 1797516378939326464
author Woo Yeon Hwang
Wook Ha Park
Dong Hoon Suh
Kidong Kim
Yong Beom Kim
Jae Hong No
author_facet Woo Yeon Hwang
Wook Ha Park
Dong Hoon Suh
Kidong Kim
Yong Beom Kim
Jae Hong No
author_sort Woo Yeon Hwang
collection DOAJ
description Difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase (ODC), has promising activity against various cancers and a tolerable safety profile for long-term use as a chemopreventive agent. However, the anti-tumor effects of DFMO in ovarian cancer cells have not been entirely understood. Our study aimed to identify the effects and mechanism of DFMO in epithelial ovarian cancer cells using SKOV-3 cells. Treatment with DFMO resulted in a significantly reduced cell viability in a time- and dose-dependent manner. DFMO treatment inhibited the activity and downregulated the expression of ODC in ovarian cancer cells. The reduction in cell viability was reversed using polyamines, suggesting that polyamine depletion plays an important role in the anti-tumor activity of DFMO. Additionally, significant changes in Bcl-2, Bcl-xL, Bax protein levels, activation of caspase-3, and cleavage of poly (ADP-ribose) polymerase were observed, indicating the apoptotic effects of DFMO. We also found that the effect of DFMO was mediated by AP-1 through the activation of upstream JNK via phosphorylation. Moreover, DFMO enhanced the effect of cisplatin, thus showing a possibility of a synergistic effect in treatment. In conclusion, treatment with DFMO alone, or in combination with cisplatin, could be a promising treatment for ovarian cancer.
first_indexed 2024-03-10T07:01:14Z
format Article
id doaj.art-f2144808744a433e8b53f7fdcf1f6e82
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T07:01:14Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-f2144808744a433e8b53f7fdcf1f6e822023-11-22T16:06:48ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-09-0122191025510.3390/ijms221910255Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian CancerWoo Yeon Hwang0Wook Ha Park1Dong Hoon Suh2Kidong Kim3Yong Beom Kim4Jae Hong No5Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam 13620, KoreaDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam 13620, KoreaDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam 13620, KoreaDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam 13620, KoreaDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam 13620, KoreaDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam 13620, KoreaDifluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase (ODC), has promising activity against various cancers and a tolerable safety profile for long-term use as a chemopreventive agent. However, the anti-tumor effects of DFMO in ovarian cancer cells have not been entirely understood. Our study aimed to identify the effects and mechanism of DFMO in epithelial ovarian cancer cells using SKOV-3 cells. Treatment with DFMO resulted in a significantly reduced cell viability in a time- and dose-dependent manner. DFMO treatment inhibited the activity and downregulated the expression of ODC in ovarian cancer cells. The reduction in cell viability was reversed using polyamines, suggesting that polyamine depletion plays an important role in the anti-tumor activity of DFMO. Additionally, significant changes in Bcl-2, Bcl-xL, Bax protein levels, activation of caspase-3, and cleavage of poly (ADP-ribose) polymerase were observed, indicating the apoptotic effects of DFMO. We also found that the effect of DFMO was mediated by AP-1 through the activation of upstream JNK via phosphorylation. Moreover, DFMO enhanced the effect of cisplatin, thus showing a possibility of a synergistic effect in treatment. In conclusion, treatment with DFMO alone, or in combination with cisplatin, could be a promising treatment for ovarian cancer.https://www.mdpi.com/1422-0067/22/19/10255AP-1apoptosisDFMOJNKovarian cancerpolyamines
spellingShingle Woo Yeon Hwang
Wook Ha Park
Dong Hoon Suh
Kidong Kim
Yong Beom Kim
Jae Hong No
Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer
International Journal of Molecular Sciences
AP-1
apoptosis
DFMO
JNK
ovarian cancer
polyamines
title Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer
title_full Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer
title_fullStr Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer
title_full_unstemmed Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer
title_short Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer
title_sort difluoromethylornithine induces apoptosis through regulation of ap 1 signaling via jnk phosphorylation in epithelial ovarian cancer
topic AP-1
apoptosis
DFMO
JNK
ovarian cancer
polyamines
url https://www.mdpi.com/1422-0067/22/19/10255
work_keys_str_mv AT wooyeonhwang difluoromethylornithineinducesapoptosisthroughregulationofap1signalingviajnkphosphorylationinepithelialovariancancer
AT wookhapark difluoromethylornithineinducesapoptosisthroughregulationofap1signalingviajnkphosphorylationinepithelialovariancancer
AT donghoonsuh difluoromethylornithineinducesapoptosisthroughregulationofap1signalingviajnkphosphorylationinepithelialovariancancer
AT kidongkim difluoromethylornithineinducesapoptosisthroughregulationofap1signalingviajnkphosphorylationinepithelialovariancancer
AT yongbeomkim difluoromethylornithineinducesapoptosisthroughregulationofap1signalingviajnkphosphorylationinepithelialovariancancer
AT jaehongno difluoromethylornithineinducesapoptosisthroughregulationofap1signalingviajnkphosphorylationinepithelialovariancancer